Literature DB >> 8267382

Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment.

A Comandone1, S Bretti, G La Grotta, S Manzoni, G Bonardi, R Berardo, C Bumma.   

Abstract

Palmar-Plantar Erythrodysestasia Syndrome (PPES) or Hand-Foot Syndrome (H&F S) is an underestimated adverse reaction to chemotherapeutic agents, mainly related to 5-Fluorouracil. From March 1991 to February 1992, at the San Giovanni Oncologic Hospital of Torino, we observed 12 out of 163 patients (7.3%) displaying PPES while being treated with 5-FU containing regimens. No correlation with type of neoplastic disease, sex, age and total dose of administered 5FU was observed. Dose reductions or drug suspension achieved PPES reversal. The etiopathogenesis remains unclear. Both an idiosyncratic pattern and cutaneous drug accumulation are suggested.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8267382

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  3 in total

1.  Pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancer.

Authors:  S Stremetzne; M Streit; E D Kreuser; W Schunack; U Jaehde
Journal:  Pharm World Sci       Date:  1999-08

2.  Topical henna for capecitabine induced hand-foot syndrome.

Authors:  Idris Yucel; Gonullu Guzin
Journal:  Invest New Drugs       Date:  2007-09-21       Impact factor: 3.850

3.  Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women's cancers. Results of a prospective study.

Authors:  Mark Hackbarth; Norbert Haas; Christina Fotopoulou; Werner Lichtenegger; Jalid Sehouli
Journal:  Support Care Cancer       Date:  2007-08-07       Impact factor: 3.603

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.